Member Info for Redditchrocket

He can be buck nekkit for all I care, just don't film it on a fish eye camera

There was a moment in the pitching video where I'm sure Paul said that we got paid for every car that rolls off the line but I may have been mistaken

But you'll never know if you were too soon until you were too late, if you're comfortable then just chill. Thats what i'm trying to do anyways

I don't buy this whole notion that COPD is on hold.

I get that it has been said in the RNS and in interviews but surely getting the approval for Covid massively increases the ease by which you need approval for COPD, its essentially had its safety case bolstered and in essence its a re-re-purposed drug.

So i see it as being on hold in name but any progress made gets us closer to long term opportunity with COPD.

In the latest update to the trials website the home trials criteria seemed vastly expanded to those over 50 so I think that would make it easier to help more people

I see in the TILS RNS today that they intend to spin out the Stemprinter business and launch it via IPO rather than RTO so I think that rules that one out of the equation...

Maybe the Prime session just finished (jokes)

Just going to comment that this wasn't an RNS with material information it was listed as an RNS Reach which is slightly different. Definition below:-

Reach is an investor communication service aimed at assisting listed and unlisted companies to deliver non-regulatory news such as marketing messages, corporate and product information. It is based on the existing RNS UK-Regulatory service and has the same levels of efficiency, control and broad dissemination.

Reach also enables unlisted and foreign-listed companies to deliver their news to a professional UK financial audience. Announcements are released automatically on the London Stock Exchange corporate website (“Market News” section) as well as other data vendors such as Bloomberg, Thomson Reuters (Refinitiv) and Dow Jones terminals.

Other vendors subscribing for Reach announcements will receive announcements sent through this channel but may choose not to display for editorial reasons.

Yes it seems like a volunteered piece of research that hasn't been considered or responded to from an individual member of the labour party to their policy forum. Seemed to download in IE but failed in Chrome.

Can't get a link to work for this, anyone have a copy or able to copy and paste relevant parts?

Ok thanks for confirming, I'll struggle to invest then but wish you all the best

Hi everyone, is there a reason why I can't add this share to my SIPP? It says 'this security is restricted from dealing' any ideas? That's on AJBell

Definitely not a cross ramp as this is in relation to Nikola and follows on from GM taking a big stake in them yesterday.

A friend sent me this link about the Nikola backstory and it was frankly too unbelievable not to share it. If it doesn't make a movie one day, I'll eat my hat!

https://hindenburgresearch.com/nikola/

Quoting Mr Vallance -

'There will be other such drugs coming along that impact the disease, whether thats to modify hospitalised care or whether its to prevent infection with antivirals which are now being tried in specific anti coronavirus drugs are now being developed. And there are produced antibodies, so not ones made in the body, but ones made actually in a laboratory which can then be given back in to patients that are now being trialed as well that may have an effect to prevent the virus' - so there's good progress on the drug front...

Did anyone catch the exact wording of the 2nd treatment option they discussed, it was a bit jumbled and i couldn't work out if they were trying to mention us but not by name?

It does seem like he draws attention to a good detail that it would be potentially in our interest to vote against the special resolution. I don't know the ins and outs of that though...

I'm obviously not explaining what I intended very well and I am fairly tired. I had intended it to be more like a 'Right to Try' construct aimed at experimental drug treatments.

Everyone here wants this approved and available for all and I am no different, in that scenario my suggestion is moot.

But anyways as you say, happy to draw a line under it and move on as it's clearly not a popular idea.

As I said, it assumes that the drug is readily available (as it should be if production of millions of doses is on the way for Q4) and that it is awaiting final approvals.

And my opinion (which you clearly disagree with and I respect that) is that if be even more annoyed If I succumbed to a virus when half of my life savings were in a drug that was safe and appeared to work that was being held back for no good reasons.

That would be my definition of annoying.

Hey everyone, bit quiet in here...

Could someone tell me why this isn't an excellent RTO target with all these tax losses?

@monticello - it's fairly common practice for there to be added benefits of being a shareholder.

https://www.barclays.co.uk/smart-investor/investments/shareholder-benefits/